As people around the world ring in the new year, it is important that time is taken to look at what can be expected in 2019. The new year will more than likely be a pivotal one for the cannabis industry in terms of both legalization and progression in general. In the United States, it
Co-founder of Project CBD Martin Lee, speaks with Democracy Now! about the recent changes to marijuana laws, which he has written about through his longtime work as an investigative reporter. He is also a Co-founder of FAIR (Fairness and Accuracy in Reporting) and author of several books, including “Acid Dreams: The Complete Social History of
By Fred Gardner | Published in O’Shaughnessy’s A three-judge panel from the Ninth Circuit Court of Appeals has upheld a 10-year mandatory minimum sentence for Bryan Epis, 42, the first California medical marijuana grower convicted in federal court in the Prop 21 era, Jay Bybee was one of those three judges. The jugdes’ 11-page decision
Two-year old Cash Hyde was weened off of 125mg of various prescriptions after father turned to marijuana oil to save the life of his son after brain cancer had taken over the toddler. All too often, parents worry about their children about the wrong dangers and for Cash’s father, he had had enough. Seeing very
By CBDiary | Published in ProjectCBD.org Remember when we reported on the 24th that the National Cancer Institute, U.S. National Institutes of Health, had finally recognized the antitumor properties of Cannabis?: “The potential benefits of medicinal Cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep. In the practice
Fifteen members of the Society of Cannabis Clinicians -the doctors’ group founded by Tod Mikuriya in 1999 and now led by Jeffrey Hergenrather- met in Oakland Dec. 11 (2009.) UCSF professor Donald Abrams recounted the obstacles he faced in conducting clinical trials with government-issued cannabis and getting his results published in peer-reviewed medical journals. The ensuing discussion focused on how SCC doctors might go about evaluating the effectiveness of high-CBD strains as they become available to patients in the year ahead.